Biopharmaceutical Purification
Biopharmaceutical Innovation. Pure and Simple.
We understand there’s tremendous pressure to increase speed to clinicals and lower manufacturing costs. Like you, we’re scientists and engineers devoted to increasing the number and availability of life-saving pharmaceuticals. We’ll work with you to optimize your processes, applying our biopharma experience, material science and proprietary technologies to help you develop highly effective purification solutions.
Biopharmaceutical Applications
-
Recombinant Proteins
At 3M, we're advancing the recombinant protein industry by helping build better, more efficient manufacturing processes, developing solutions that allow process compression, and enhanced drug recovery that leads to improved process economics.
-
Vaccines
At 3M, our products and solutions help design and develop manufacturing process for virus-like particles . These are designed for impurity removal in harvest & clarification which help maximize downstream purity.
-
Plasma Fractionation
3M has been servicing the plasma fractionation industry for more than 30 years. We offer a range of products including depth filters, chromotography products, and membrane products, all of which are supported by our validation services offerings.
-
Chemical Pharmaceuticals
3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical industry. These products may be used for a range of applications including catalyst removal and recovery, color removal, particulate filtration and fill-finish.
Explore Product Solutions
Need help streamlining your process?
Our experts will work with you to help find the optimal 3M purification and filtration solution for your application and to test our products within your process. We also provide trial data when we work with you to demonstrate product in-use.
Industry News
Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimization of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.
-
Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification
-
Frost & Sullivan: Perspective on Next Generation Harvest Techniques
-
Frost & Sullivan: Transition to Next Gen Downstream Processing to Capitalize on Growth Opportunities in High-Value Low-Volume Biologics
-
BioProcess Int'l: Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
-
Frost & Sullivan: Enabling Novel Bioprocessing Technologies Using the Interface of Materials Science Biotechnology
-
Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies
-
Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives
-
Frost & Sullivan: Commercialization Strategies in Global Biosimilars Industry
Industry Awards
-
3M™ Emphaze™ AEX Hybrid Purifier recognized as global product leader
2017 Frost & Sullivan Global Biologics Product Leadership Award. With its next generation technology product, the 3M™ Emphaze™ AEX Hybrid Purifier, 3M demonstrates leadership in meeting specific customer needs.
-
3M™ Emphaze™ AEX Hybrid Purifier recognized at MN Tekne Award
2018 Minnesota Tekne Biotech/Pharmaceutical Award. MN Tekne Awards celebrate innovation and pioneering efforts in biotechnology or pharmaceuticals to provide game-changing advancement in the healthcare field.